Patents Assigned to Aerovate Therapeutics, Inc.
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11813263
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: November 14, 2023
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11806349
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: January 24, 2022
    Date of Patent: November 7, 2023
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11464776
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: October 11, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11413289
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: August 16, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11298355
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 12, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin
  • Inhalable imatinib formulations, manufacture, and uses thereof
    Patent number: 11229650
    Abstract: The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: January 25, 2022
    Assignee: Aerovate Therapeutics, Inc.
    Inventors: Ben Dake, Ralph Niven, Andrew D. Levin